This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biocon Biologics India Limited, Biocon Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations by Sai Srikar Kandukuri
Introduction
Sai Srikar Kandukuri is an accomplished inventor based in Guntur, India. He has made significant contributions to the field of biotechnology, particularly in the area of insulin production. With a total of 2 patents to his name, Kandukuri's work focuses on improving the efficiency and quality of insulin manufacturing processes.
Latest Patents
Kandukuri's latest patents include innovative methods for the crystallization of recombinant human insulin. The first patent discloses a method for crystallizing recombinant human insulin at both lab and manufacturing scales. This method utilizes a mixture of zinc chloride and sodium chloride, along with a higher concentration of organic solvent (IPA-19 to 25 million). The pH is adjusted to 5.0 at a rapid rate of ≤5 minutes. This approach also incorporates procedures to reduce settling time and alter holding temperatures, facilitating consistent protein crystal formation between 15 μm-30 μm and enhancing the robustness of the process.
The second patent describes an integrated automated filtration process for the separation, washing, and drying of peptide crystals. This invention combines preparative crystallization, crystal separation, washing, and freeze-drying processes into a single continuous operation using pressure filtration. The process significantly reduces time and introduces a novel design that employs multiple organic solvent washes and nitrogen gas purging to remove imbibed water, ensuring the final drug substance meets quality specifications.
Career Highlights
Throughout his career, Kandukuri has worked with notable companies such as Biocon Limited and Biocon Biologics India Limited. His experience in these organizations has contributed to his expertise in biopharmaceutical processes and innovations.
Collaborations
Kandukuri has collaborated with talented individuals in his field, including Vibhava Shukla and Qais Shabandri. These collaborations have further enriched his work and contributed to the advancements in insulin production technologies.
Conclusion
Sai Srikar Kandukuri is a prominent inventor whose innovative approaches to insulin manufacturing have the potential to enhance the efficiency and quality of biopharmaceutical products. His contributions to the field are noteworthy and reflect his commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
